Freedom Investment Management Inc. upped its Bristol-Myers Squibb stake by 51.3%, scooping up 6,040 extra shares and ending ...

Not only are pharmaceutical stocks excellent defensive investments, some pharma stocks pay sizable dividends that can be a ...

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Novo Nordisk (NYSE:NVO) stock has experienced a significant decline, dropping 35% from over $90 in early March to around $58 ...

Despite worries about an economic slowdown, Netflix continues to prove itself to be a recession-resistant stock.

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Most U.S. stocks rose, but the worst drop for UnitedHealth Group in a quarter century kept Wall Street in check ...

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...

Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial ...

The first GLP-1 pill could be in medicine cabinets sooner than expected. Eli Lilly (LLY) announced Thursday that its daily ...

The days when they’d get enough pills to last 6 months are gone. Now, Zambian government clinics are rationing HIV drugs. The ...